Based on this evidence, recent studies suggest the clinical utility of evaluating Gal-1, -3, -8, and -9 circulating levels as novel potential diagnostic and prognostic biomarkers of COVID-19 either alone or in conjunction with other known biomarkers (19–22). Here, LGALS1 is linked to COVID-19.